Zevra Therapeutics, Inc. ZVRA Proceeds From Warrant Exercises
Proceeds From Warrant Exercises at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s proceeds from warrant exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s proceeds from warrant exercises?
- Zevra Therapeutics, Inc. (ZVRA) reported proceeds from warrant exercises of $9.17M in Q1 2026.
- What does proceeds from warrant exercises mean?
- Indicates the cash proceeds received by the company when holders of warrants exercise their rights to purchase common stock at a predetermined strike price. This metric reflects the conversion of derivative instruments into equity, providing a non-dilutive or dilutive cash infusion depending on the market context.